CMV infection attenuates the disease course in a murine model of multiple sclerosis

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Pirko, Istvan ^a   Cardin, Rhonda ^b   Chen, Yi ^a   Lohrey, Anne K ^a   Lindquist, Diana M ^b   Dunn, R Scott ^b   Zivadinov, Robert ^c   Johnson, Aaron J ^a  

^a MAYO CLINIC   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B220+ T CELL; BRAIN ATROPHY; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD45+ T CELL; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DISEASE COURSE; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; IMMUNOMODULATION; IN VIVO STUDY; LYMPHOCYTE COUNT; MAC1+ T CELL; MIXED INFECTION; MOTOR PERFORMANCE; MOUSE; MULTIPLE SCLEROSIS; MURINE ENCEPHALOMYELITIS VIRUS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PILOT STUDY; ROTAROD TEST; T LYMPHOCYTE; ANIMAL; BIOSYNTHESIS; BRAIN; DEMYELINATING DISEASE; DISEASE MODEL; ENCEPHALITIS; FLOW CYTOMETRY; IMMUNE SYSTEM; INFLAMMATION; METHODOLOGY; PATHOLOGY; REPRODUCIBILITY; TIME; VIROLOGY;

MAIZE CHLOROTIC MOTTLE VIRUS; MURINAE; MUS; THEILER'S ENCEPHALOMYELITIS VIRUS;

CD3 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN;

ANIMALS; ANTIGENS, CD3; ANTIGENS, CD45; ANTIGENS, CD8; BRAIN; CYTOMEGALOVIRUS INFECTIONS; DEMYELINATING DISEASES; DISEASE MODELS, ANIMAL; ENCEPHALITIS; FEMALE; FLOW CYTOMETRY; IMMUNE SYSTEM; INFLAMMATION; MICE; MULTIPLE SCLEROSIS; REPRODUCIBILITY OF RESULTS; TIME FACTORS;

EID: 84863273460     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032767     Document Type: Article

References (48)

1. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG, (2000) Multiple sclerosis. N Engl J Med 343: 938-952.
2. Zuvich RL, McCauley JL, Pericak-Vance MA, Haines JL, (2009) Genetics and pathogenesis of multiple sclerosis. Semin Immunol 21: 328-333.
3. Handel AE, Giovannoni G, Ebers GC, Ramagopalan SV, (2010) Environmental factors and their timing in adult-onset multiple sclerosis. Nat Rev Neurol 6: 156-166.
4. Ascherio A, Munger KL, Simon KC, Vitamin D, and multiple sclerosis (2010) Lancet Neurol 9: 599-612.
5. Ascherio A, Munger KL, Lennette ET, Spiegelman D, Hernan MA, et al. (2001) Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study. JAMA 286: 3083-3088.
6. Barzilai O, Sherer Y, Ram M, Izhaky D, Anaya JM, et al. (2007) Epstein-Barr virus and cytomegalovirus in autoimmune diseases: are they truly notorious? A preliminary report. Ann N Y Acad Sci 1108: 567-577.
7. Wroblewska Z, Gilden D, Devlin M, Huang ES, Rorke LB, et al. (1979) Cytomegalovirus isolation from a chimpanzee with acute demyelinating disease after inoculation of multiple sclerosis brain cells. Infect Immun 25: 1008-1015.
8. Zivadinov R, Nasuelli D, Tommasi MA, Serafin M, Bratina A, et al. (2006) Positivity of cytomegalovirus antibodies predicts a better clinical and radiological outcome in multiple sclerosis patients. Neurol Res 28: 262-269.
9. Alcami A, Koszinowski UH, (2000) Viral mechanisms of immune evasion. Immunol Today 21: 447-455.
10. Mocarski ES Jr, (2004) Immune escape and exploitation strategies of cytomegaloviruses: impact on and imitation of the major histocompatibility system. Cell Microbiol 6: 707-717.
11. Rodriguez M, Oleszak E, Leibowitz J, (1987) Theiler's murine encephalomyelitis: a model of demyelination and persistence of virus. Crit Rev Immunol 7: 325-365.
12. Denic A, Johnson AJ, Bieber AJ, Warrington AE, Rodriguez M, et al. (2011) The relevance of animal models in multiple sclerosis research. Pathophysiology: the official journal of the International Society for Pathophysiology/ISP 18: 21-29.
13. Fields BN, Knipe DM, Howley PM, Griffin DE, (2001) Fields virology Philadelphia Lippincott Williams & Wilkins pp. xix, 3087.
14. Pirko I, Johnson AJ, Chen Y, Lindquist DM, Lohrey AK, et al. Brain atrophy correlates with functional outcome in a murine model of multiple sclerosis. Neuroimage 54: 802-806.
15. Pirko I, Johnson AJ, Chen Y, Lindquist DM, Lohrey AK, et al. (2011) Brain atrophy correlates with functional outcome in a murine model of multiple sclerosis. Neuroimage 54: 802-806.
16. Bray PF, Bloomer LC, Salmon VC, Bagley MH, Larsen PD, (1983) Epstein-Barr virus infection and antibody synthesis in patients with multiple sclerosis. Arch Neurol 40: 406-408.
17. Sanders VJ, Felisan S, Waddell A, Tourtellotte WW, (1996) Detection of herpesviridae in postmortem multiple sclerosis brain tissue and controls by polymerase chain reaction. J Neurovirol 2: 249-258.
18. Myhr KM, Riise T, Barrett-Connor E, Myrmel H, Vedeler C, et al. (1998) Altered antibody pattern to Epstein-Barr virus but not to other herpesviruses in multiple sclerosis: a population based case-control study from western Norway. J Neurol Neurosurg Psychiatry 64: 539-542.
19. Jilek S, Schluep M, Meylan P, Vingerhoets F, Guignard L, et al. (2008) Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis. Brain 131: 1712-1721.
20. Jaquiery E, Jilek S, Schluep M, Meylan P, Lysandropoulos A, et al. Intrathecal immune responses to EBV in early MS. Eur J Immunol 40: 878-887.
21. Benedict CA, Loewendorf A, Garcia Z, Blazar BR, Janssen EM, (2008) Dendritic cell programming by cytomegalovirus stunts naive T cell responses via the PD-L1/PD-1 pathway. Journal of immunology 180: 4836-4847.
22. Kano Y, Shiohara T, (2000) Current understanding of cytomegalovirus infection in immunocompetent individuals. J Dermatol Sci 22: 196-204.
23. Sweet C, (1999) The pathogenicity of cytomegalovirus. FEMS Microbiol Rev 23: 457-482.
24. Mocarski ES Jr, (2002) Immunomodulation by cytomegaloviruses: manipulative strategies beyond evasion. Trends Microbiol 10: 332-339.
25. Rubin RH, (1989) The indirect effects of cytomegalovirus infection on the outcome of organ transplantation. JAMA 261: 3607-3609.
26. Beersma MF, Bijlmakers MJ, Ploegh HL, (1993) Human cytomegalovirus down-regulates HLA class I expression by reducing the stability of class I H chains. J Immunol 151: 4455-4464.
27. Heise MT, Connick M, Virgin HWt, (1998) Murine cytomegalovirus inhibits interferon gamma-induced antigen presentation to CD4 T cells by macrophages via regulation of expression of major histocompatibility complex class II-associated genes. J Exp Med 187: 1037-1046.
28. Heise MT, Pollock JL, O'Guin A, Barkon ML, Bormley S, et al. (1998) Murine cytomegalovirus infection inhibits IFN gamma-induced MHC class II expression on macrophages: the role of type I interferon. Virology 241: 331-344.
29. Percivalle E, Revello MG, Vago L, Morini F, Gerna G, (1993) Circulating endothelial giant cells permissive for human cytomegalovirus (HCMV) are detected in disseminated HCMV infections with organ involvement. J Clin Invest 92: 663-670.
30. Benedict CA, Banks TA, Senderowicz L, Ko M, Britt WJ, et al. (2001) Lymphotoxins and cytomegalovirus cooperatively induce interferon-beta, establishing host-virus detente. Immunity 15: 617-626.
31. Tsunoda I, Libbey JE, Fujinami RS, (2007) Sequential polymicrobial infections lead to CNS inflammatory disease: possible involvement of bystander activation in heterologous immunity. J Neuroimmunol 188: 22-33.
32. Selin LK, Vergilis K, Welsh RM, Nahill SR, (1996) Reduction of otherwise remarkably stable virus-specific cytotoxic T lymphocyte memory by heterologous viral infections. J Exp Med 183: 2489-2499.
33. Selin LK, Lin MY, Kraemer KA, Pardoll DM, Schneck JP, et al. (1999) Attrition of T cell memory: selective loss of LCMV epitope-specific memory CD8 T cells following infections with heterologous viruses. Immunity 11: 733-742.
34. Silverman MN, Miller AH, Biron CA, Pearce BD, (2004) Characterization of an interleukin-6- and adrenocorticotropin-dependent, immune-to-adrenal pathway during viral infection. Endocrinology 145: 3580-3589.
35. Silverman MN, Pearce BD, Biron CA, Miller AH, (2005) Immune modulation of the hypothalamic-pituitary-adrenal (HPA) axis during viral infection. Viral Immunol 18: 41-78.
36. Manrique SZ, Correa MA, Hoelzinger DB, Dominguez AL, Mirza N, et al. (2011) Foxp3-positive macrophages display immunosuppressive properties and promote tumor growth. The Journal of experimental medicine 208: 1485-1499.
37. Doedens AL, Stockmann C, Rubinstein MP, Liao D, Zhang N, et al. (2010) Macrophage expression of hypoxia-inducible factor-1 alpha suppresses T-cell function and promotes tumor progression. Cancer research 70: 7465-7475.
38. Pirko I, Johnson AJ, Lohrey AK, Chen Y, Ying J, (2009) Deep gray matter T2 hypointensity correlates with disability in a murine model of MS. J Neurol Sci.
39. Pirko I, Suidan GL, Rodriguez M, Johnson AJ, (2008) Acute hemorrhagic demyelination in a murine model of multiple sclerosis. J Neuroinflammation 5: 31.
40. Stoddart CA, Cardin RD, Boname JM, Manning WC, Abenes GB, et al. (1994) Peripheral blood mononuclear phagocytes mediate dissemination of murine cytomegalovirus. J Virol 68: 6243-6253.
41. Stoddart CA, Cardin RD, Boname JM, Manning WC, Abenes GB, et al. (1994) Peripheral blood mononuclear phagocytes mediate dissemination of murine cytomegalovirus. Journal of virology 68: 6243-6253.
42. Cardin RD, Schaefer GC, Allen JR, Davis-Poynter NJ, Farrell HE, (2009) The M33 chemokine receptor homolog of murine cytomegalovirus exhibits a differential tissue-specific role during in vivo replication and latency. Journal of virology 83: 7590-7601.
43. Robb RA, (1999) 3-D visualization in biomedical applications. Annu Rev Biomed Eng 1: 377-399.
44. Robb RA, (2001) The biomedical imaging resource at Mayo Clinic. IEEE Trans Med Imaging 20: 854-867.
45. McDole J, Suidan G, Boespflug E, Cheng J, Chen Y, et al. (2008) A translatable molecular approach to determining CD8 T-cell epitopes in TMEV infection. Hum Immunol 69: 805-810.
46. McDole JR, Danzer SC, Pun RY, Chen Y, Johnson HL, et al. (2010) Rapid formation of extended processes and engagement of Theiler's virus-infected neurons by CNS-infiltrating CD8 T cells. Am J Pathol 177: 1823-1833.
47. Johnson AJ, Njenga MK, Hansen MJ, Kuhns ST, Chen L, et al. (1999) Prevalent class I-restricted T-cell response to the Theiler's virus epitope Db:VP2121-130 in the absence of endogenous CD4 help, tumor necrosis factor alpha, gamma interferon, perforin, or costimulation through CD28. J Virol 73: 3702-3708.
48. Lyman MA, Lee HG, Kang BS, Kang HK, Kim BS, (2002) Capsid-specific cytotoxic T lymphocytes recognize three distinct H-2D(b)-restricted regions of the BeAn strain of Theiler's virus and exhibit different cytokine profiles. J Virol 76: 3125-3134.